Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). ...
Obesity has been linked to numerous health conditions, including high blood pressure, high cholesterol, type 2 diabetes, heart disease and strokes. Identifying neural processes underpinning excessive eating and obesity could ...
Johns Hopkins University researchers have found that nearly all adults identified as having obesity based on body mass index (BMI) also had confirmed excess adiposity.
Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the incidence of 16 common health outcomes. Associations remained consistent across sex and racial groups. ...
Delicious and extremely palatable food can increase the tendency of hedonic eating, where one consumes food for the sole purpose of deriving pleasure instead of the body's energy needs. Hedonic eating often leads to eating ...
The mammalian immune system is an evolutionary wonder. It's capable of recognizing and destroying cancer cells, and it can deploy armies of antibodies against viruses, bacteria, parasites and fungi.
University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that tirzepatide and semaglutide provide ...
Researchers from Oxford University, University College London, and collaborating institutions across Germany, France, and the Netherlands, found that diet quality and waist-to-hip ratio during midlife are associated with ...
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as Ozempic—in suppressing appetite and reducing body weight. Notably, testing in animals also showed ...
Mar 6, 2025
0
301
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy ...
